STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Total Revenues	$ 41,893	$ 458,260
Costs and Expenses
Costs of revenue	148,376	1,892,341
Research, development and manufacturing operations	2,300,948	3,222,283
Selling, general and administrative	4,506,337	5,364,523
Share-based compensation	1,024,758	2,243,445
Depreciation and amortization	74,142	95,238
Impairment loss	524,481	3,283,715
Total Costs and Expenses	8,579,042	16,101,545
Loss from Operations	(8,537,149)	(15,643,285)
Other Income/(Expense)
Other income/(expense), net	818,721	747,739
Warrant settlement (Note 16)	(743,462)
Interest expense	(665,718)	(2,174,118)
Total Other Income/(Expense)	(590,459)	(1,426,379)
Income/(Loss) on Equity Method Investment	(2,666)	(232)
Net Income/(Loss)	(9,130,274)	(17,069,896)
Less: Series 1C preferred stock dividends	(33,301)
Less: Down round deemed dividend		(17,980,678)
Net Income Available to Common Shareholders	$ (9,163,575)	$ (35,050,574)
Net Income/(Loss) Per Share (Basic)	$ (10.38)	$ (3,419)
Net Income/(Loss) Per Share (Diluted)	$ (10.38)	$ (3,419)
Weighted Average Common Shares Outstanding (Basic)	882,547	10,251
Weighted Average Common Shares Outstanding (Diluted)	882,547	10,251
Other Comprehensive Income/(Loss)
Foreign currency translation gain/(loss)	$ (4,014)	$ 24,960
Net Comprehensive Income/(Loss)	(9,134,288)	(17,044,936)
Products
Total Revenues	$ 41,893	397,886
Milestone and engineering
Total Revenues		$ 60,374